Accredited Continuing Education . . . Any Course . . . Any Time . . . Any Where

Comprehensive Respiratory Medicine

Full Course - 20 Credits/$490.00 • Short Course - 10 Credits/$395.00

The Comprehensive Respiratory Medicine Review Course outlined below provides healthcare professionals with up to 20AMA PRA Category 1 CreditsTMin continuing medical education, or CME. ASI has provided quality accredited continuing medical education seminars for 30 years. The following continuing medical education, or CME, review course in Comprehensive Respiratory Medicineis provided in a convenient and portable format, perfect for travel and ideal for busy healthcare professionals.

Add to Cart

 For a Limited Time
We are offering this course at a substantial discount.
Take advantage of this opportunity while supplies last !!
Short course 1A~ Save $70 off the regular price
This offer may not be combined with other discounts.  Course must be completed on or before April 1, 2012.

Breathing (Not So) Easy: Dyspnea and Pneumonia Patrick A. Flume, M.D. Detail the differential diagnosis for patients with chronic dyspnea. Evaluate patients with chronic dyspnea, distinguishing between cardiac, pulmonary, Pulmonary-vascular and neuromuscular causes. Describe the changes in lung function that are associated with obstructive and restrictive lung diseases. Compare community-acquired, health care-associated, hospital-acquired and ventilator-associated pneumonias with regard to etiology, common pathogens and approach to management. Discuss the importance of initial antibiotic therapy for patients with pneumonia and the factors to consider when selecting antibiotics. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

Diseases of the Airway: A Clinical Perspective Robert M. Jasmer, M.D. and Catherin J. Rees, M.D. Review risk factors for Mycobacterium tuberculosis exposure and infection, as well as factors that cause reactivation of latent TB. Screen patients for TB using the tuberculin skin test or interferon-release assays. Describe the treatment and monitoring of patients with active TB. Discuss common and unusual causes of chronic cough, and methods to diagnose them. Treat chronic cough using multidrug approaches and speech pathology. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

Managing Diseases of the Airway Michael T. Fitch, M.D., Ph.D., Judith M.E. Walsh, M.D., M.P.H. and Gregory P. Kalemkerian, M.D. Distinguish viral from bacterial causes of acute bronchitis and acute sinusitis, based on clinical findings. Recognize patients with acute sinusitis who may benefit from antibiotic therapy. List advantages of using low-dose spiral computed tomography for lung cancer screening. Select an adjuvant chemotherapy regimen for eligible patients with lung cancer. Describe the role of monoclonal antibodies such as bevacizumab in the treatment of lung cancer. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

What's New in Pediatric Asthma C. Michael Bowman, M.D., Ph.D. List key elements of current asthma guidelines. Recognize signs of uncontrolled asthma. Assess asthma severity and control. Counsel families and patients about proper use of rescue and controller medications. Address environmental factors, such as tobacco smoke. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

Threats to Lung Function: What Can We Do About Them? Stephen I. Rennard, M.D. and William E. Chavey, M.D., M.S. Describe the pharmacologic addiction and conditioned responses to nicotine. Discuss the outcomes of nicotine replacement therapy, as well as other pharmacologic therapies for smoking cessation. Distinguish cravings from other withdrawal symptoms associated with smoking cessation. Explain the spirometric classification system determined by the Global Initiative for Chronic Obstructive Lung Disease. Manage COPD using a combination of nonpharmacologic and pharmacologic approaches. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

Techniques in Airway Management Ron M. Walls, M.D. and Benjamin B. Cable, M.D. Establish airway assessment protocols based on statistical evidence of expected difficulties. Evaluate newer technologies designed to improve airway assessment and management. Choose and organize tools for use in airway management procedures. Establish improved airway management procedural protocols involving the use of newer technologies. Perform safe and effective airway management techniques on children undergoing airway surgical procedures. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

Pediatric Airways: Little People, Big Disasters Ghazala Sharieff, M.D. Determine the most appropriate method of providing airway support in any given case. Utilize formulas to determine the appropriate size of a cuffed and uncuffed endotracheal tube and rates of ventilation for various stages of resuscitation. Review the indications and contraindications for each pretreatment medication and intubating agent. Confirm proper airway placement. Manage airway obstruction due to a foreign body. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

Breathless: An Asthma Tutorial Alan G. Kaplan, M.D. Distinguish asthma from other respiratory disorders, such as chronic obstructive pulmonary disease or Karta gener syndrome. Use effective screening tools to diagnose and monitor asthma. Counsel patients about controlling reflux-induced symptoms and triggers. Describe patterns of asthma exacerbations during pregnancy. Select effective and safe therapy for asthma during pregnancy.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

Update on Asthma Michael J. Waxman, M.D. Summarize current data on the prevalence and impact of asthma. Accurately diagnose the patient who presents with signs of asthma. Evaluate the severity of a patient’s asthma, using the most recent National Asthma Education and Prevention Program (NAEPP) guidelines. Achieve and maintain long-term control of a patient’s asthma. Reduce the risk for potential adverse effects of asthma therapy. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

Lung Disease Kevin P. Fennelly, M.D. and Paul J. Wolters, M.D. Evaluate the patient with suspected NTM pulmonary disease. Prescribe effective medical therapy for the patient with a minimal, fibrocavitary, or severe Mycobacterium aviumcomplex (MAC) lung infection. Distinguish between the disease patterns of individual types of ILDs. Summarize recent and ongoing research on new medical therapies for idiopathic pulmonary fibrosis. Implement treatment for nonspecific interstitial pneumonitis and hypersensitivity pneumonitis. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™

Here's what our clients are saying about American Seminar Institute's CME seminars...

“ I continue to appreciate ASI’s continuing medical education seminar services after 12+ years of using them." Mark, PA-C, Berea, KY

"..the flexibility (of ASI's continuing medical education seminars) is incredible!” Wendy,MD,Las Vegas, NV

CRM (1)
042109-112110
Add to Cart